What is Tarsus Pharmaceuticals, Inc.'s change in AR?

Tarsus Pharmaceuticals, Inc. (TARS) reported change in AR of $30.29M in Q1 2026.

How has Tarsus Pharmaceuticals, Inc.'s change in AR changed year-over-year?

Tarsus Pharmaceuticals, Inc.'s change in AR increased by 93.3% year-over-year, from $15.67M to $30.29M.

What does change in AR mean?

Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.

Tarsus Pharmaceuticals, Inc. TARS Change in AR

Change in AR at other companies

AbbVieABBV

-$87M-106%

Bausch + LombBLCO

-$108M-135%

Ocular TherapeutixOCUL

-$6.3M+12.1%

Regeneron PharmaceuticalsREGN

-$1.2M+99.8%

Warby ParkerWRBY

-$1.52M-221%

GlaukosGKOS

$12.46M+1.2%

Other financials

Income statement

See full

Revenue$162.1M+107%

Gross profit$152.7M+109%

Operating income-$6.1M+76.7%

Net income-$7.0M+72.3%

EPS (diluted)-$0.16+75.0%

Balance sheet

See full

Cash & equivalents$104.2M-41.6%

Total debt$88.7M+22.5%

Total equity$349.0M+1.9%

Total assets$581.1M+16.1%

Cash flow

See full

Operating cash flow-$24.7M-19.4%

CapEx$5.8M+886%

Free cash flow-$30.5M-43.4%

Valuation

See full

Market cap$2.85B+41.1%

Enterprise value$2.83B+47.8%

P/S5.3×-3.3×

Profitability

See full

Gross margin42.7%—

Operating margin-9.5%-4.2pp

Net margin-9%-4.0pp

FCF margin-28%-12.6pp

Returns & leverage

See full

Return on equity-14%-5.2pp

Debt / equity0.3×0.0×

Current ratio3.7×-1.8×

Where this comes from

Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tarsus Pharmaceuticals, Inc.'s change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tarsus Pharmaceuticals, Inc.'s change in AR?: Tarsus Pharmaceuticals, Inc. (TARS) reported change in AR of $30.29M in Q1 2026.
How has Tarsus Pharmaceuticals, Inc.'s change in AR changed year-over-year?: Tarsus Pharmaceuticals, Inc.'s change in AR increased by 93.3% year-over-year, from $15.67M to $30.29M.
What does change in AR mean?: Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.